electroCore (ECOR) Debt to Equity (2017 - 2026)

electroCore (ECOR) recorded quarterly Debt to Equity of -$1.18 in Q1 2026, up 69.59% quarter-over-quarter from -$3.87 in Q4 2025.

electroCore (ECOR) Debt to Equity (2017 - 2026) Analysis & Trends

electroCore's Debt to Equity history runs 5 years deep, the most recent figure standing at -$1.18 for Q1 2026.

In Q1 2026, Debt to Equity changed N/A year-over-year to -$1.18; the TTM figure through Mar 2026 stood at -$1.18 (changed N/A YoY), while the FY2025 annual figure was -$3.87, changed N/A from the prior year.
Debt to Equity was -$1.18 for Q1 2026 at electroCore, up from -$3.87 in the prior quarter.
In the past five years, Debt to Equity ranged from a high of -$1.18 in Q1 2026 to a low of -$6.08 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.65
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.64
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.57
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.42
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.06
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.71
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.95
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.27
10	electroCore	75,742.38	-8.80 Mn	8.36 Mn	-1.18

Download Data